Trial | NCT00047775  Report issue

Title

African-American Heart Failure Trial

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    1100
A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.
The overall objective is confirmation of BiDil's Safety and Efficacy in African-American (AFA) Patients with Moderate to Severe Symptomatic Heart Failure.
Study Started
May 31
2001
Study Completion
Aug 31
2004
Last Update
Jun 24
2005
Estimate

Drug BiDil

Criteria 

African American male or female 18 years or older.
NYHA Class 3 & 4.
Have either a resting LVEF less than or equal to 35% (by any method) or a resting LVIDD greater than 2.9 cm/m2 BSA (or greater than 6.5 cm) with LVEF less than 45% (by echocardiogram).
No Results Posted